Omega-3 Fatty Acids
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11133 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | tendinitis | KG + DL |
| 2 | Glanzmann thrombasthenia | KG + DL |
| 3 | amenorrhea (disease) | KG + DL |
| 4 | myositis fibrosa | KG + DL |
| 5 | idiopathic granulomatous myositis | KG + DL |
| 6 | primary release disorder of platelets | KG + DL |
| 7 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 8 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 9 | fibromyalgia | KG + DL |
| 10 | pseudo-von Willebrand disease | KG + DL |
| 11 | thromboangiitis obliterans | KG + DL |
| 12 | antithrombin deficiency type 2 | KG + DL |
| 13 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 14 | diabetic nephropathy | KG + DL |
| 15 | heparin cofactor 2 deficiency | KG + DL |
| 16 | inclusion body myositis | KG + DL |
| 17 | thrombophilia | KG + DL |
| 18 | thrombotic disease | KG + DL |
| 19 | breast fibrocystic disease | KG + DL |
| 20 | hemoglobinopathy | KG + DL |
| 21 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 22 | rheumatoid arthritis | KG + DL |
| 23 | peripheral arterial disease | KG + DL |
| 24 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 25 | blunt duct adenosis of breast | KG + DL |
| 26 | apocrine adenosis of breast | KG + DL |
| 27 | exostosis | KG + DL |
| 28 | angiodysplasia | KG + DL |
| 29 | non-inflammatory vasculopathy | KG + DL |
| 30 | benign mammary dysplasia | KG + DL |
| 31 | Scott syndrome | KG + DL |
| 32 | vein disease | KG + DL |
| 33 | venous thromboembolism | KG + DL |
| 34 | fibrocartilaginous embolism | KG + DL |
| 35 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 36 | ischemic disease | KG + DL |
| 37 | cholecystolithiasis | KG + DL |
| 38 | autosomal dominant macrothrombocytopenia | KG + DL |
| 39 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 40 | priapism | KG + DL |
| 41 | beta-thalassemia with other manifestations | KG + DL |
| 42 | breast adenosis | KG + DL |
| 43 | pyropoikilocytosis, hereditary | KG + DL |
| 44 | lactation disease | KG + DL |
| 45 | vascular ectasia | KG + DL |
| 46 | gout | KG + DL |
| 47 | congenital renal artery stenosis | KG + DL |
| 48 | breast abscess | KG + DL |
| 49 | fat necrosis of breast | KG + DL |
| 50 | myocardial infarction (disease) | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.